Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-09

Clinical Trial Update: Assessment of Medrol Dosepak to Reduce Opioid Consumption in Foot and Ankle Surgical Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from Emory University is evaluating whether a Medrol Dosepak (methylprednisolone dose pack) can reduce opioid consumption after foot an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Medrol Dosepak (methylprednisolone)

Snippet

Sponsor: Emory University | Conditions: Foot Injuries and Disorders, Ankle Injuries and Disorders | Phase 2 | Status: RECRUITING